Liquidity and Capital Resources Cash, cash equivalents and short-term interest-bearing investments. Cash, cash equivalents and short-term interest-bearing investments, net of short-term debt, totaled $1.13 billion as of September 30, 2013, compared to $0.92 billion as of September 30, 2012. The increase during fiscal 2013 was mainly attributable to $670.5 million in cash flow from operations and $213.4 million of proceeds from stock options exercised, partially offset by $367.1 million used to repurchase our ordinary shares, $112.4 million in net cash paid for an acquisition, $106.7 million for capital expenditures, net and $84.0 million of cash dividend payments. Net cash provided by operating activities amounted to $670.5 million and $514.1 million for fiscal 2013 and 2012, respectively. Our policy is to retain sufficient cash balances in order to support our growth. We believe that our current cash balances, cash generated from operations and our current lines of credit will provide sufficient resources to meet our operational needs and to fund share repurchases and the payment of cash dividends for at least the next fiscal year. Our interest-bearing investments are classified as available-for-sale securities. Such short-term interest- bearing investments consist primarily of money market funds, U.S. government treasuries, corporate bonds and U.S. agency securities. We believe we have conservative investment policy guidelines. Our interest-bearing investments are stated at fair value with the unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax. Our interest-bearing investments are priced by pricing vendors and are classified as Level 1 or Level 2 investments, since these vendors either provide a quoted market price in an active market or use other observable inputs to price these securities. Please see Notes 4 and 5 to our consolidated financial statements. Revolving Credit Facility, Letters of Credit and Guarantees. In 2011, we entered into an unsecured $500.0 million five-year revolving credit facility with a syndicate of banks. The credit facility is available for general corporate purposes, including acquisitions and repurchases of ordinary shares that we may consider from time to time. The interest rate for borrowings under the revolving credit facility is chosen at our option from several pre- defined alternatives, depends on the circumstances of any advance and is based in part on our credit rating. As of September 30, 2013, we were in compliance with the financial covenants under the revolving credit facility. In September 2013, we borrowed an aggregate of $200.0 million under the facility and repaid it in October 2013. As of September 30, 2013, we had several uncommitted lines of credit available for general corporate and other specific purposes. As of September 30, 2013, we had outstanding letters of credit and bank guarantees from various banks totaling $64.3 million. Capital Expenditures. Our capital expenditures, net, were approximately $106.7 million in fiscal 2013. Approximately 80%-90% of these expenditures consisted of purchases of computer equipment, with the remainder attributable mainly to leasehold improvements. Our fiscal 2013 capital expenditures were mainly attributable to investments in our operating facilities and our development centers around the world. Our policy is to fund our capital expenditures from operating cash flows, and we do not anticipate any changes to this policy in the foreseeable future. Share Repurchases. From time to time, our board of directors has adopted share repurchase plans authorizing the repurchase of our outstanding ordinary shares. Our current share repurchase plan authorizes the repurchase of up to $500.0 million of our outstanding ordinary shares with no expiration date. In fiscal 2013, we repurchased 10.4 million ordinary shares at an average price of $35.38 per share (excluding broker and transaction fees). As of September 30, 2013, we had remaining authority to repurchase up to $335.9 million of our outstanding ordinary shares. The authorization permits us to purchase our ordinary shares in open market or privately negotiated transactions at times and prices that we consider appropriate. 37